Scherzer & Co AG

Scherzer & Co AG has a basic and diluted share count of 26,731,043, indicating no dilution pressure from share issuance in the current period. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is not available, limiting the ability to assess its current market valuation relative to peers.

Profitability and return metrics are not available for Scherzer & Co AG, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without these metrics, it is not possible to determine whether the company is outperforming or underperforming its peers in terms of return on equity, net profit margin, or other key financial indicators.

Segment and geographic exposure data are not disclosed in the available source documents, preventing an analysis of revenue concentration or geographic diversification. This lack of transparency limits the ability to assess the company's exposure to regional economic risks or the performance of its different business lines.

Growth trajectory data is not available for Scherzer & Co AG, and no numeric deltas or revenue history are provided to evaluate its performance over time. Analysts have assigned a mean price target of 3.17 EUR, with a median of 3.17 EUR, and a mean recommendation of 1.50 (1=strong buy, 5=strong sell). This suggests a generally positive outlook, but the absence of historical revenue data limits the ability to validate this assessment.

Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and no going-concern language in source documents. The company is currently assessed to have low dilution risk, and no adjustments have been applied to its valuation metrics. However, the lack of detailed financial data increases the uncertainty around its risk profile.

Recent events and filings are not disclosed in the available source documents, preventing an analysis of any recent developments that may impact the company's operations or financial performance. The absence of transcripts or filings limits the ability to assess management's strategic direction or any material changes in the company's business model.

Net income surged 238.3% year-over-year to EUR 4.85 million, demonstrating significant recent profitability improvement.

Operating income increased 107.7% year-over-year to EUR 4.90 million, indicating strong operational leverage and efficiency gains.

Analysts assign a strong buy recommendation with a mean price target of EUR 3.18, implying 17.6% upside.

Total assets grew 7.2% year-over-year to EUR 86.46 million, reflecting continued balance sheet expansion despite revenue headwinds.

Equity increased 5.4% year-over-year to EUR 73.06 million, supporting a solid capital base for future operations.

Total assets contracted at a 4.0% compound annual growth rate over four years, suggesting long-term balance sheet shrinkage.

Revenue €8.3M, −57,5% YoY; Operating income −29,5% YoY.

• ▍Revenue €8.3M, −57,5% YoY
• ▍Operating income −29,5% YoY
• ▍Net income −4,2% YoY
• ▍Net margin -10.0%

Revenue €18.2M; Operating income €11.7M.

• ▍Revenue €18.2M
• ▍Operating income €11.7M
• ▍Net margin 64.0%